Citation

Scientist.com
Approved Supplier
×

Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.
location: Home > Citation >

Citation

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Knockout Cell Lines Culture Medium

Citation

Engineered Cell Line
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Culture Medium
Engineered Microbe
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Culture Medium
Plasmid/Virus
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Culture Medium
Products
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Culture Medium
CRISPR Library
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
Related Service or Product: Culture Medium
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
IF=6.5
Pharmaceutics
Author: Fang Wang 1, 2, †ORCID, Yu Deng 2, †, Luying Yu 2, †, Ao Zhou 2, Jieting Wang 2, Jingyan Jia 2, Ning Li 2ORCID, Fadian Ding 3, Wei Lian 3, Qicai Liu 3, Yu Yang 4, * andXinhua Lin 2, *
Related Service or Product: Culture Medium
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma
IF=5.6
International Immunopharmacology
Author: Yan Xu, Fang Sun, Yuying Tian, Guineng Zeng, Guanglin Lei, Zhifang Bai, Yonggang Wang, Xinlan Ge, Jing Wang, Chaohui Xiao, Zhaohai Wang, Minggen Hu, Jianxun Song, Penghui Yang, Rong Liu
Related Service or Product: Knockout Cell Lines Culture Medium

×

Search documentation

Literature:

Name: *

Company: *

Telephone: *

Email:

Notes: After submitting the order, we will contact you as soon as possible.

request now
Contact us

Contact us

If we are unable to reach you via email, how else can we contact you?
Submission Succeeded